Therapeutic Drug Monitoring
moNATor® from Abreos Biosciences was designed to measure the amount of Tysabri in your blood. This information may help optimize your treatment intervals, potentially reducing PML risk.
If you’re impacted by multiple sclerosis (MS) you may know that using Tysabri (natalizumab), while clinically proven to be beneficial, comes with risks.
Specifically, the risk of progressive multifocal leukoencephalopathy (PML) which has a 25% fatality rate.
Laboratory Diagnostic Test for Natalizumab
Healthcare Provider Information Brochure
FOR MORE INFORMATION
EMAIL | PHONE (858)203-1169